Research has examined its role in: 3-adrenergic receptor upregulation and adipose tissue sensitisation studies Lipolysis stimulation and plasma glycerol elevation in adipocyte models Lipogenesis inhibition and fat accumulation prevention in diet-induced obesity models Fat oxidation and energy expenditure pathway research Metabolic flexibility and substrate oxidation studies in obese murine models Cartilage regeneration and intra-articular joint biology in osteoarthritis models Safety pharmacology genotoxicity, bioavailability, and plasma kinetics profiling Comparative hGH fragment activity studies alongside AOD9401 and native hGH AOD9604 and Adipose Tissue Research In obese Zucker rats treated with oral AOD9604 at 500 g/kg body weight for 19 days, over 50% reduction in body weight gain was observed compared to controls, accompanied by significantly increased lipolytic activity in adipose tissue
Most obesity drugs may suppress appetite or food absorption, but only few actually stimulate fat metabolism like the peptide AOD-9604, which has also been tested as an obesity drug in humans
Start with a 0.5 percent AHK-Cu formulation applied once daily
Why NAD(+) Declines During Aging: It's Destroyed
Blossom leads our injectable therapy program, specializing in Vitamin B12 + MIC (Methionine, Inositol, Choline) injections designed to support metabolism, energy, and overall vitality
Current areas of scientific investigation include cellular energy metabolism studies, mitochondrial signaling investigations, metabolic pathway coordination research, NAD pathway analysis, NNMT inhibitor research, and multi-compound metabolic signaling studies
